CD303 (BDCA-2) Immunostain, Technical Component Only
Use
CD303 (BDCA-2) is a highly specific marker for normal and neoplastic plasmacytoid dendritic cells and is useful for diagnosing blastic plasmacytoid dendritic cell neoplasm. This marker is expressed in the cytoplasm/membrane of plasmacytoid dendritic cells, aiding in the specific identification of these cells in neoplastic transformations.
Special Instructions
Not provided.
Limitations
This test does not include pathologist interpretation, only technical performance of the stain. Interpretation should be carried out by a qualified pathologist based on the patient's clinical history and other diagnostic tests. The stability of paraffin sections may vary depending on antigen type and literature reports suggest cutting sections within 6 weeks for optimal results. The charge of glass slides can also affect staining results, emphasizing the importance of correct storage and handling.
FDA ApprovedNew York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CD303 (BDCA-2)
Protein
LOINC Codes
- CD303
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Immunostain Technical Only Envelope
Storage Instructions
Store slides minimizing time after being unpackaged and limit exposure to humidity and heat.
Causes for Rejection
Wet/frozen tissue, Cytology smears, Nonformalin fixed tissue, Nonparaffin embedded tissue, Noncharged slides, ProbeOn slides, Snowcoat slides will be rejected.